Developing Induced Proximity Drugs with ADCs to Demonstrate Improved Potency & Selectivity Profiles

Time: 9:30 am

Details:

• What motivates the integration of ADCs with induced proximity drugs?
• How do ADCs enhance the therapeutic approach compared to standalone strategies?
• How are antibodies designed and optimized for ADCs targeting epigenetic regulators in the context of induced proximity?